First FDA-approved genetic therapy fights leukemia

The first gene therapy treatment has been approved for use in the United States. The FDA greenlit a procedure that uses a patient’s own cells to combat a particular type of leukemia, but will only permit it for children and young adults up to age 25.

This procedure, known as Kymriah (tisagenlecleucel), works to combat acute lymphoblastic leukemia (ALL), the most common childhood cancer in the US with over 3,000 new cases diagnosed every year. Kymriah extracts a patient’s autoimmune T-cells and sends them to a facility, where they are modified to include a new gene that directs the T-cells to target particular leukemia cells. Then the genetically-modified cells are sent back to be re-inserted in the patient.

“Kymriah is a first-of-its-kind treatment approach that fills an important unmet need for children and young adults with this serious disease,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research (CBER), in the FDA’s post. “Not only does Kymriah provide these patients with a new treatment option where very limited options existed, but a treatment option that has shown promising remission and survival rates in clinical trials.”

One study cited in the FDA’s announcement treated 63 children and young adult patients with Kymriah, which saw an 83 percent remission rate after three months. The agency granted approval of the gene therapy to Novartis Pharmaceuticals Corp.

Source: FDA

Source: Engadget - Read the full article here

Author: Daily Tech Whip

This article is part of our 'News Tiles' service. The site is currently in Beta. When it is fully operational you will be able to search through and arrange the 'Tiles' to display a keyword, product or technology over your chosen time period. For example you would be able to display all of the leading tech articles on the new Kindle Fire, in one spot in real time. You will also have access to our own original reporting and analysis as well as a polished place to post your own thoughts & reviews here, amongst the Daily Tech Whip Community. Please let us know if you have any feedback via the contact form or via Twitter. Don't forget to come back next week and see our full site and claim your name and your own free tech blog.

Share This Post On